However, due to the pleiotropic nature of NGF action, the effect of inhibiting NGF-TrkA signalling in arthritis treatment remains controversial, and it is not clear whether there are significant negative effects (Walsh and Neogi, 2019). This evidence concerns the gene NTRK1 and arthritic joint disease.